MHR celebration issue in tribute to Professor Sir Robert Edwards.

Bob Edwards died earlier this year and will be sadly missed by all those who knew him. Recognition of his outstanding contributions came rather late in his career but finally, in 2010, he was awarded the Nobel Prize for Physiology or Medicine. Bobs achievements have been widely documented on a number of different occasions. Amongst these he set upMolecular Human Reproduction (MHR) and as such we wanted to take a slightly different approach to honour his work. The development of IVF centred on two breakthrough papers. The first described the fertilization in vitro of human eggs (Edwards et al., 1969) and the second was the report of the first birth from IVF (Steptoe and Edwards, 1978). We identified three main challenges, which we believed were fundamental problems faced by Bob to achieve these breakthroughs, namely (i) capacitation for successful fertilization (ii)maturation of eggs in vitro (iii) developing successful stimulation regimes to recover eggs and allow full term development. We invited internationally leading authors to discuss these subjects specifically with the broad remit to provide a background on the challenges Bob faced, hence providing a context to his achievements, and then to speculate how their field is likely to develop. John Aitken addresses the issue of capacitation. It is difficult now to imagine, when there are a plethora of different media and protocols to capacitate sperm, that it was such a conundrum. Prior to 1969, the focus was to understand how capacitation occurred in the female tract and what factors were involved—the overall aim being to reconstitute the environment in vitro. It is perhaps ironic today that almost all we know about sperm transport comes from work prior to the 1980s with minimal progress since—hopefully this will change. In 1951, capacitation was discovered independently by Austin and Chang yet it took a further 17 years to achieve this in vitro in humans. The importance of the problem is reflected by the sentence in Introduction of the Nature paper in 1969: ‘a possible solution to the problem of obtaining “capacitated” spermatozoa has emerged from experiments on hamster’ (Edwards et al., 1969). Interestingly, despite four and an half decades of research examining capacitation there is still much to learn about this enigmatic process and John expertly guides us through this tricky maze. A second fundamental challenge was the need to successfully mature humaneggs in vitro. Bobmadepivotal contributions in this areadescribing the timing of in vitromaturation (IVM) in humans, whichwas considerably longer that he first anticipated or was led to believe. Rob Gilchrist and Jeremy Thompson elegantly describe this incredibly productive part of his career and document his critical insight. Although Bob successfully achieved IVM and fertilization, he judged, that for the clinical development of IVF, in vivo matured oocytes would be needed. The reason being the limited embryonic developmental capacity of IVM mature oocytes. Remarkably, almost 50 years after successful IVM in humans safe clinical IVM remains a technical challenge and Jeremy and Rob identify six key areas that require urgent attention if the potential of IVM is to be fully realized. In turning to in vivomaturation for the potential to achieve healthy live births, different problems presented themselves. Rudimentary stimulation regimes to achieve conception in vivo were available but the control of these processes and the recovery of eggs at the appropriate stages to support development were key issues. Steve Hillier eloquently provides a context to these developments. Remarkably, despite consistent failure Bob deemed it essential to use in vivomaturation of eggs and ingeniously turned to the natural cycle. To achieve this it was necessary